Related by context. All words. (Click for frequent words.) 76 epithelial ovarian 76 metastatic gastric 75 recurrent metastatic 75 recurrent NSCLC 74 primary peritoneal 74 LHRH receptor positive 73 prostate cancer HRPC 73 nonmetastatic 73 stage IIIB 73 leukemia AML 73 situ CIS 73 metastatic malignant 72 pancreatic adenocarcinoma 72 metastatic bladder 72 metastatic renal cell carcinoma 72 non resectable 71 chemotherapy cisplatin 71 peritoneal cancer 71 operable breast cancer 71 bevacizumab Avastin ® 71 dacarbazine DTIC 71 IV NSCLC 71 unresectable 70 Surgical resection 70 Paraplatin ® 70 metastatic pancreatic 70 metastatic GIST 70 metastatic colorectal 70 anthracycline taxane 70 recurrent glioblastoma multiforme 70 tumors GIST 70 5 fluorouracil leucovorin 70 basal cell carcinoma BCC 70 Mitomycin C 70 unresectable tumors 70 prostate carcinoma 69 gemcitabine Gemzar 69 Doxil ® 69 cytoreductive surgery 69 cetuximab Erbitux R 69 relapsed MM 69 cell carcinoma RCC 69 fallopian tube cancers 69 sorafenib Nexavar 69 hormone refractory metastatic prostate 69 relapsed ovarian cancer 69 papillary renal cell carcinoma 69 prostate cancer mCRPC 69 gemcitabine carboplatin 69 advanced unresectable 69 metastatic adenocarcinoma 69 prostate cancer CRPC 69 mRCC 69 gastrointestinal stromal tumor GIST 69 Irinotecan 69 malignant pleural mesothelioma 69 metastatic ovarian cancer 69 epithelial tumors 69 neuroendocrine carcinoma 69 resectable 69 hepatic metastases 69 Neoadjuvant 69 NMIBC 69 KRAS mutations occur 69 cisplatin gemcitabine 69 pancreatic NET 69 cisplatin chemotherapy 69 myelodysplastic myeloproliferative diseases 69 Soft Tissue Sarcoma 69 cell lymphoma CTCL 68 prostate adenocarcinoma 68 transplantation HCT 68 chemoradiotherapy 68 taxane chemotherapy 68 Aflibercept 68 Pegylated Interferon 68 alfa 2a 68 FOLFOX6 68 taxane resistant 68 ribavirin Copegus ® 68 endometrial hyperplasia 68 monoclonal antibody conjugated 68 gemcitabine chemotherapy 68 dasatinib Sprycel ® 68 gastrointestinal stromal tumors GIST 68 denileukin diftitox 68 refractory ovarian cancer 68 metastatic HER2 positive 68 colorectal carcinoma 68 metastatic malignant melanoma 68 irinotecan chemotherapy 68 advanced metastatic renal 68 urothelial bladder cancer 68 interferon alfa 2a 68 docetaxel chemotherapy 68 stage IIIb IV 68 clinically localized prostate 68 docetaxel Taxotere ® 68 debulking surgery 68 unresectable locally advanced 68 gefitinib Iressa 68 breast carcinoma 68 metastatic neuroendocrine tumors 68 grade cervical intraepithelial 68 vinca alkaloids 68 adenomatous 68 histologically confirmed 67 adjuvant radiation 67 erlotinib Tarceva ® 67 unresectable stage 67 prostate carcinomas 67 essential thrombocythemia ET 67 superficial bladder cancer 67 Hodgkin lymphoma HL 67 alkylating agent 67 cytoreduction 67 fluorouracil leucovorin 67 Peg IFN 67 non squamous NSCLC 67 radiotherapy RT 67 adjuvant radiotherapy 67 cetuximab Erbitux ® 67 concurrent chemoradiation 67 paclitaxel carboplatin 67 unresectable liver cancer 67 localized renal 67 resistant hormone refractory 67 treat benign prostatic 67 invasive ductal 67 Hepatocellular Carcinoma HCC 67 urothelial carcinoma 67 metastatic RCC 67 Anaplastic 67 gastrointestinal stromal tumor 67 Selective Internal 67 advanced epithelial ovarian 67 mycophenolate mofetil 67 transarterial 67 5 FU leucovorin 67 chemoembolization 67 radiochemotherapy 67 interferon ribavirin 67 endocrine therapies 67 opioid induced constipation OIC 67 chemoradiation therapy 67 Myelodysplastic Syndrome MDS 67 HER2 positive metastatic breast 67 colorectal liver metastases 67 Adjuvant chemotherapy 67 pegylated liposomal doxorubicin 67 adriamycin 67 ThermoDox R 67 hepatocellular cancer 67 CYT# potent vascular disrupting 67 refractory chronic lymphocytic 67 FOLFOX4 67 peritoneal carcinomatosis 67 metastatic castration resistant 67 temozolomide Temodar 67 FUSILEV enhances 67 biliary tract cancer 67 recurrent glioblastoma 67 leiomyomas 67 pT2 66 artery embolization 66 colorectal cancer liver metastases 66 demonstrated antitumor activity 66 invasive candidiasis 66 renal tumors 66 resistant ovarian cancer 66 malignant ascites 66 Fludara ® 66 metastatic carcinoma 66 acute GvHD 66 abacavir Ziagen 66 Malignant Melanoma 66 bladder ovarian 66 locoregional recurrence 66 radiofrequency ablation RFA 66 non splenectomized 66 carboplatin paclitaxel 66 microwave hyperthermia 66 evaluating tivozanib 66 underwent resection 66 stage IIIB IV 66 carcinoma HCC 66 hyperplasia BPH 66 transitional cell carcinoma 66 refractory NSCLC 66 ipsilateral breast 66 papillary carcinoma 66 Motexafin Gadolinium 66 HER2 negative 66 seminoma 66 estramustine 66 trabectedin 66 skeletal metastases 66 cervical intraepithelial neoplasia 66 gastric adenocarcinoma 66 basal cell skin 66 metastatic renal 66 refractory cutaneous T 66 recurrent ovarian cancer 66 ErbB2 positive 66 posterior uveitis 66 taxane therapy 66 Gliadel Wafer 66 allogeneic hematopoietic stem cell 66 vinca alkaloid 66 Flu Cy 66 precancerous cervical lesions 66 cholelithiasis 66 immunomodulatory therapy 66 neoadjuvant 66 non resectable metastatic 66 gastrointestinal stromal tumors 66 relapsed multiple myeloma 66 Vidaza azacitidine 66 R lenalidomide 66 ductal breast cancer 66 locoregional 66 oral clodronate 66 neoplasias 66 ALA PDT 66 assessing T DM1 66 5-FU/LV 66 symptomatic benign prostatic 66 receptor tyrosine kinase inhibitor 66 dacarbazine 66 relapsing remitting MS RRMS 66 mitoxantrone plus 66 irinotecan doxorubicin oxaliplatin paclitaxel 66 pancreatic carcinoma 66 Bezielle 66 paclitaxel cisplatin 66 Paraplatin ® carboplatin 66 ovarian fallopian tube 66 receiving prophylactic anticoagulation 66 ribavirin RBV 66 ® lenalidomide 66 urothelial cancer 66 Nilotinib 66 deep venous thromboses 66 BCG refractory carcinoma 66 valsartan amlodipine 66 HBeAg negative 66 Cloretazine 65 superficial basal cell carcinoma 65 Squamous 65 cyclophosphamide methotrexate 65 EGFR expressing 65 CTAP# Capsules 65 neoadjuvant therapy 65 Hormone Refractory Prostate Cancer 65 pegylated interferon alfa 2a 65 ABVD 65 paclitaxel Taxol 65 radiation sensitizer 65 Relapsed Refractory 65 FASLODEX 65 FOLFIRI 65 metastatic castrate resistant 65 non squamous 65 CTAP# 65 Peginterferon alfa 2b 65 Folfox 65 standard chemotherapy regimen 65 intraepithelial neoplasia 65 bronchogenic carcinoma 65 preoperative chemotherapy 65 MAGE A3 ASCI 65 gemcitabine cisplatin 65 doxorubicin HCl liposome injection 65 Patients Treated With 65 alpha interferons 65 flutamide 65 intravesical instillation 65 Gemzar ® 65 cell lymphoma ALCL 65 lymphoid malignancies 65 VELCADE melphalan 65 chemo radiotherapy 65 systemic anaplastic large 65 smoldering myeloma 65 bevacizumab Avastin 65 cervical carcinoma 65 capecitabine Xeloda 65 GISTs 65 TTF Therapy 65 metastatic HER2 negative 65 arthritis PsA 65 anthracyclines taxanes 65 contralateral breast 65 IV melanoma 65 Endometrial 65 clodronate 65 dasatinib Sprycel 65 Ophena TM 65 acetonide FA 65 completely resected 65 leukemia CLL 65 Albuferon TM 65 Hurthle cell 65 complement inhibitor eculizumab 65 mg/m2 dose 65 anterior uveitis 65 Platinol ® 65 Peginterferon 65 neoadjuvant treatment 65 Accelerated Partial Breast Irradiation 65 relapsed refractory multiple myeloma 65 hepatocellular carcinoma HCC 65 neoplasia 65 Amrubicin 65 Benign Prostatic Hyperplasia BPH 65 Copegus ribavirin 65 squamous cell carcinoma SCC 65 lymphadenopathy 65 Pemetrexed 65 TKI therapy 65 Capecitabine 65 refractory colorectal cancer 65 Naive Patients 65 hepatorenal syndrome 65 acute myeloid 65 autoantibody positive 65 situ LCIS 65 pertuzumab 65 overactive bladder syndrome 65 imatinib Gleevec ® 65 Carcinoma 65 Fludarabine 65 platinum refractory 65 intestinal metaplasia 65 castrate resistant 65 recurrent malignant glioma 65 TACE 65 ovarian carcinoma 65 grade glioma 65 pain palliation 65 radiation chemoradiation 65 Complicated Skin 65 nonsmall cell lung cancer 65 chronic ITP patients 65 pan HDAC inhibitor 65 bevacizumab Avastin R 65 Glioblastoma Multiforme 65 hemorrhagic cystitis 65 sorafenib tablets 65 Advanced Renal Cell 65 pediatric malignancies 65 vincristine doxorubicin 65 EBRT 65 FluCAM arm 65 Cutaneous T 65 underwent surgical resection 65 cholangiocarcinoma 65 ovarian lung 65 thalidomide Thalomid 65 relapsed CLL 65 neoplasm 65 biochemical relapse 65 differentiated thyroid 65 invasive aspergillosis 65 IV metastatic melanoma 65 aromatase inhibitor AI 65 liver metastasis 65 curative resection 65 HNSCC 64 metastatic CRC 64 gastroesophageal junction 64 acute leukemias 64 ara C 64 lexidronam injection 64 epithelial ovarian cancer 64 neoadjuvant setting 64 malignant pleural mesothelioma MPM 64 Vicinium TM 64 sarcomatoid 64 tamoxifen citrate 64 relapsing multiple sclerosis 64 Acute Myeloid Leukaemia AML 64 cutaneous melanoma 64 Actinic Keratosis 64 esophageal candidiasis 64 systemic ALCL 64 osteoporotic vertebral compression fractures 64 remission induction 64 breast carcinomas 64 histologic subtype 64 oropharyngeal candidiasis OPC 64 metastatic lung cancer 64 unresectable HCC 64 ZACTIMA 64 castration resistant prostate cancer 64 Vidaza ® 64 solar keratoses 64 resectable pancreatic cancer 64 leiomyosarcoma 64 Etoposide 64 luteinizing hormone releasing 64 ovarian cervical 64 antithymocyte globulin 64 MELAS 64 trastuzumab Herceptin ® 64 epithelioid 64 thromboembolisms 64 undergone radical prostatectomy 64 SCCHN 64 paclitaxel Taxol R 64 distant metastasis 64 idarubicin 64 Gleevec imatinib mesylate 64 histological subtype 64 hypervascular tumors 64 parathyroid carcinoma 64 carcinoid tumors 64 BARACLUDE ® 64 verteporfin 64 paclitaxel poliglumex 64 liver metastases 64 progesterone receptor negative 64 Radiation Therapy SIRT 64 RCW breast cancer 64 LHRH agonists 64 Navelbine ® 64 allogeneic bone marrow 64 Intravitreal 64 SHPT 64 Xeloda capecitabine 64 castrate resistant prostate cancer 64 bladder carcinoma 64 interferon beta 1a infertility 64 5 Fluorouracil 64 Nexavar sorafenib 64 polycythemia vera essential thrombocythemia 64 mycosis fungoides 64 intraperitoneal chemotherapy 64 carmustine 64 Cell Lymphoma 64 malignant lymphomas 64 Caelyx 64 recurrent prostate cancer 64 adjuvant cisplatin 64 ritonavir boosted 64 trastuzumab Herceptin R 64 invasive lobular carcinoma 64 Chronic Lymphocytic Leukemia CLL 64 alkylating agents 64 bone metastases 64 vinorelbine tartrate 64 Idiopathic Pulmonary Fibrosis 64 transarterial chemoembolization 64 cytotoxic therapy 64 cisplatin vinorelbine 64 nodal metastasis 64 Xelox 64 liposomal formulation 64 hypercalcemia 64 cancer mCRC 64 serologically active systemic lupus 64 PEGylated anti 64 Bevacizumab Avastin 64 BRCA deficient 64 NATRECOR ® 64 refractory multiple myeloma 64 Papillary 64 Percutaneous Transluminal Coronary Angioplasty 64 premalignant lesion 64 lenalidomide Revlimid R 64 radioiodine therapy 64 docetaxel Taxotere R 64 thymoma 64 refractory CTCL 64 TO AVOID PREGNANCY WHILE 64 histologically proven 64 metastatic basal cell 64 nucleoside analog 64 refractory AML 64 Xeloda ® 64 PEGINTRON TM 64 minimally symptomatic metastatic castrate 64 intravesical therapy 64 Diffuse Large B 64 severe neutropenia 64 external beam radiotherapy 64 sunitinib Sutent 64 antimetabolite 64 vinorelbine 64 baseline LDH 64 neoadjuvant chemotherapy 64 GW# [003] 64 topically administered 64 hematological diseases 64 nasopharyngeal cancer 64 mucinous 64 bleomycin 64 liver resection 64 AA Amyloidosis 64 advanced hepatocellular carcinoma 64 Lenalidomide 64 indolent follicular non 64 Camptosar ® 64 5FU 64 follicular thyroid cancer 64 metastatic androgen independent 64 Platinol ® cisplatin 64 standard chemotherapy regimens 64 metastatic hormone refractory 64 relapsed leukemia 64 Mitoxantrone 64 docetaxel Taxotere 64 nonmelanoma skin cancers 64 immunocompetent patients 64 recurrent ovarian 64 endometrial carcinoma 64 Pharmacokinetics PK 64 inhibitor RG# 64 liposarcoma 64 patientswith 64 Orally administered 64 MALT lymphoma 63 demethylating agent 63 stage IIIb 63 lung metastases 63 Ductal carcinoma 63 pheochromocytoma 63 neuroendocrine cancers 63 tiuxetan 63 Proxinium TM 63 Arimidex anastrozole 63 Pathway Inhibitor 63 Adjuvant Treatment 63 bacillus Calmette Guerin 63 histone deacetylase HDAC inhibitor 63 interferon alfa 2b 63 benign prostatic hypertrophy 63 pulmonary metastases 63 calcineurin inhibitor 63 EGFR TKI 63 B Cell Lymphoma 63 papillary thyroid carcinoma 63 letrozole Femara 63 mCRC patients 63 tamoxifen Nolvadex ® 63 exemestane Aromasin 63 heavily pretreated patients 63 commercialize deforolimus 63 CLL SLL 63 hormone receptor positive 63 grade cervical dysplasia 63 liposomal doxorubicin 63 Li Fraumeni Syndrome 63 Anthracycline 63 5-fluorouracil/leucovorin 63 myeloproliferative disorders 63 atypical Hemolytic Uremic Syndrome 63 metastatic bone 63 allogeneic hematopoietic cell 63 Erlotinib 63 invasive lobular 63 SPRYCEL ® 63 allogeneic HSCT 63 Annamycin 63 PEG IFN 63 pT3 63 peritumoral brain edema 63 bladder cancers 63 Sanofi Aventis Taxotere 63 fluorouracil 63 TRAIL R1 63 familial amyloidotic polyneuropathy FAP 63 transurethral resection 63 peginterferon alfa 2a Pegasys 63 administered subcutaneously 63 EOquin TM 63 bendamustine 63 tuberous sclerosis TS 63 recurrent GBM 63 temozolomide TMZ 63 forodesine 63 acute myelogenous leukemia AML 63 Temsirolimus 63 chemotherapeutic regimens 63 small lymphocytic lymphoma 63 Omacetaxine 63 HER2 amplified 63 leukemia ALL 63 Aplidin 63 malignant neoplasms 63 endometrial cancers 63 4mg/kg 63 paraganglioma 63 HER2 overexpression 63 Ribavirin causes 63 idiopathic myelofibrosis 63 dalteparin 63 chronic HCV 63 untreated metastatic melanoma 63 refractory acute myeloid 63 nilotinib Tasigna ® 63 lymphomas leukemias 63 BCG refractory 63 Neulasta R 63 Metastatic Colorectal Cancer 63 chronic eosinophilic leukemia 63 squamous 63 cutaneous squamous cell carcinoma 63 hemodynamically significant 63 aneurysms AAA 63 TNF Tumor Necrosis Factor 63 Panzem R NCD 63 Vincristine 63 INVANZ 63 cinacalcet 63 imatinib Gleevec 63 polycythemia vera PV 63 candidemia 63 Leucovorin 63 cutaneous T 63 distant metastases 63 thoracoscopic lobectomy 63 atypical hemolytic uremic syndrome 63 Refractory Hodgkin Lymphoma 63 refractory prostate cancer 63 androgen independent 63 Ozarelix 63 FIRMAGON 63 SUPPRELIN R LA 63 nasopharyngeal carcinoma 63 Carcinoid tumors 63 Cystectomy 63 pamidronate 63 Temodar ® 63 PAOD 63 BEACOPP 63 humanised monoclonal antibody 63 PEGylated Fab fragment 63 advanced adenomas 63 ribavirin therapy 63 pancreatic lung 63 recurrent epithelial ovarian 63 gastric cancers 63 ELACYT 63 symptomatic BPH 63 gastrointestinal cancers 63 erythematosus 63 hypereosinophilic syndrome 63 metastatic squamous cell carcinoma 63 multiple myeloma MM 63 alpha1 antitrypsin deficiency 63 epirubicin cyclophosphamide 63 primary immunodeficiency PI 63 idiopathic PAH 63 potentially hepatotoxic 63 metastatic kidney 63 sunitinib malate 63 castration resistant 63 MGd 63 oral ridaforolimus 63 Rituxan rituximab 63 prostate TURP 63 docetaxel Injection Concentrate 63 INCB# [003] 63 Metastatic Prostate Cancer 63 postoperative chemotherapy 63 non metastatic osteosarcoma 63 antibody MAb 63 metastatic NSCLC 63 Adenomas 63 Eli Lilly Gemzar 63 Gemzar gemcitabine 63 colorectal adenoma 63 pelvic malignancies 63 pegfilgrastim 63 comparator arm 63 abacavir lamivudine 63 biliary cancer 63 tyrosine kinase inhibitors TKIs 63 cisplatin resistant 63 2 methoxyestradiol 63 doublet chemotherapy 63 refractory gastrointestinal stromal 63 ACTEMRA TM 63 interferon alfa 63 intra arterial chemotherapy 63 AVONEX ® 63 plus prednisone 63 intraductal 63 endoscopic resection 63 cetuximab Erbitux 63 induced macular edema 63 anastrazole 63 Intravitreal injections 63 metastatic liver 63 Xyfid TM 63 keratoplasty 63 minimally symptomatic 63 myeloid metaplasia 63 BR.# 63 temsirolimus Torisel 63 modified glutathione analog 63 fibroma 63 oral Hycamtin 63 Xanafide 63 alpha 2a 63 Atypical Hemolytic Uremic Syndrome 63 Fluorouracil 63 metastatic renal cell 63 fluoropyrimidine 63 AVASTIN 63 renal carcinoma 63 Platinol 63 recurrent colorectal cancer 63 Dacogen decitabine 63 DOXIL 63 CIN2 + 63 mg administered orally 63 Metastatic breast cancer 63 ANCA associated 63 plus DOXIL 63 Cytoxan ® 63 haematologic 63 oblimersen 63 HBeAg positive patients 63 myelofibrosis MF 63 goserelin 63 stage IIIA 63 chlorambucil 62 anti angiogenic therapy 62 VALSTAR TM 62 sorafenib Nexavar ® 62 Previously Untreated 62 Antitumor Activity 62 saline placebo 62 Waldenstrom macroglobulinemia 62 hepatocellular carcinomas 62 vWD 62 Pegylated Liposomal Doxorubicin 62 Chronic HCV 62 splenectomized 62 mTOR inhibitor 62 lupus erythematosus 62 Neulasta ® 62 Toxicities 62 leiomyoma 62 androgen deprivation 62 OZURDEX ® 62 lintuzumab SGN 62 refractory metastatic 62 Diabetic Macular Edema DME 62 glioblastoma multiforme GBM 62 hematopoietic cancers 62 Crohn disease CD 62 EGFR mutation positive 62 SCIg 62 Acute Myelogenous Leukemia 62 rituximab refractory 62 plus gemcitabine 62 HBeAg positive 62 Femara letrozole 62 Multiple Myeloma MM 62 arteriovenous malformations 62 epirubicin cisplatin 62 virus HCV infection 62 Follicular Lymphoma 62 Lupus Nephritis 62 Panzem NCD 62 Sezary syndrome 62 ductal carcinomas 62 docetaxel prednisone 62 hormone refractory 62 Myocet 62 recurrent glioblastoma multiforme GBM 62 delivers fluocinolone acetonide FA 62 chemoradiation 62 Gleevec imatinib 62 T1a 62 fibrosarcoma 62 taxane chemotherapy administered 62 Hsp# Inhibitor 62 eribulin mesylate 62 gastrointestinal stromal 62 carcinoid tumor 62 Chronic Myelogenous Leukemia CML 62 ertapenem 62 Acute myeloid leukemia 62 Hodgkin lymphoma NHL 62 colorectal neoplasms 62 Endometrial cancer 62 receiving highly emetogenic 62 Host Disease 62 evaluating picoplatin 62 neurofibromas 62 thetreatment 62 dual endothelin receptor antagonist 62 epirubicin 62 cystectomy 62 constipation OIC 62 tumor histology 62 Hycamtin ® 62 G CSFs 62 sodium stibogluconate 62 Hepatocellular Carcinoma 62 keloid scarring 62 Glioblastoma Multiforme GBM 62 Sudhir Agrawal D.Phil 62 interstitial pneumonitis 62 Combination REOLYSIN R 62 Chronic lymphocytic leukemia 62 anthracycline chemotherapy 62 palliative radiotherapy 62 colorectal adenocarcinoma 62 bexarotene 62 neurogenic bladder 62 chronic thromboembolic pulmonary 62 Camptosar ® irinotecan 62 soft tissue sarcomas 62 leukoencephalopathy 62 prostate cancer PCa 62 osteoid osteoma 62 liposomal amphotericin B 62 cytotoxic chemotherapy 62 TMP SMX 62 Voreloxin 62 Mantle Cell Lymphoma 62 Tyrosine Kinase Inhibitors 62 Adjuvant Chemotherapy 62 generation purine nucleoside 62 smoldering multiple myeloma 62 HER2 positive metastatic 62 advanced metastatic prostate 62 radiation therapy SBRT 62 Neupogen ® 62 drug zotarolimus 62 RSR# efaproxiral 62 recurrent squamous cell carcinoma 62 hypertrophic scars 62 lung pancreatic 62 bullous 62 BRCA1 mutation carriers 62 paclitaxel Taxol ® 62 benign prostatic hypertrophy BPH 62 Phase #b/#a clinical 62 Renal Cell Carcinoma RCC 62 Kepivance 62 primitive neuroectodermal tumor 62 aromatase inhibitors AIs 62 CIN3 62 Genasense ® 62 oral deforolimus 62 anthracycline containing 62 refractory myeloma 62 HCV genotype 62 anti angiogenic agents 62 Adjunctive 62 antiretroviral naïve 62 TNF antagonist 62 relapsed SCLC 62 advanced adenoma 62 FOLFIRI alone 62 irinotecan containing 62 neutropenia dehydration dyspnea 62 daunorubicin 62 colorectal metastases 62 HGS ETR1 mapatumumab 62 HRPC 62 Zavesca R 62 DCVax ® Brain 62 TLK# 62 albumin bound paclitaxel 62 sodium thiosulfate STS 62 metaplasia 62 basiliximab 62 Diabetic Neuropathy 62 Valopicitabine 62 efaproxiral 62 metastatic colorectal carcinoma 62 AGILECT R 62 R abatacept 62 unstable angina UA 62 treat chronic sinusitis 62 HGPIN 62 renal cell carcinomas 62 intracavitary 62 alfa 2b 62 orally administered inhibitor 62 metastatic pancreatic cancer 62 boosted protease inhibitor 62 Pegasys ® 62 Vulvar 62 ethambutol 62 CIMZIA TM certolizumab pegol 62 Kit CD# positive 62 PREZISTA r 62 haematological cancers 62 Afatinib 62 postmenopausal osteoporotic women 62 decompensated cirrhosis 62 Zorbtive TM 62 cidofovir 62 Decitabine 62 Stage IIIb 62 PegIFN 62 myeloproliferative disorder 62 secondary hyperparathyroidism 62 Ophena 62 targeted radiotherapeutic 62 brivanib 62 hormone refractory prostate cancer 62 chemotherapy docetaxel 62 metastatic prostate cancer 62 neoplastic lesions 62 Safinamide 62 Benign prostatic hyperplasia BPH 62 Amgen Neulasta R 62 subependymal giant cell 62 Patients Receiving 62 bone marrow reticulin deposition 62 radiolabeled TM# 62 VNP#M 62 ADPKD 62 percutaneous transluminal coronary angioplasty 62 systemic fungal infections 62 PNP inhibitor 62 oral squamous cell 62 Castration Resistant Prostate Cancer 62 advanced pancreatic neuroendocrine 62 ZOLINZA 62 CHOP chemotherapy 62 elevated transaminases 62 PEGylated interferon beta 1a 62 lymphocytic leukemia 62 terlipressin 62 Taxotere docetaxel 62 nonalcoholic steatohepatitis NASH 62 advanced medullary thyroid 62 xenograft models 62 NOLVADEX 62 adalimumab Humira 62 sclerosing 62 recurrent bladder 62 chronic myeloid 62 kidney urologic 62 5 fluorouracil 62 nadolol 62 choroidal vasculopathy 62 malignant neoplasm 62 melphalan prednisone 62 including eniluracil ADH 62 Fludara 62 Acute Coronary Syndromes ACS 62 ixabepilone 62 multivessel coronary artery 62 Meets Primary Endpoint 62 Electronic Brachytherapy System 62 prostate cancer AIPC 62 benign nodules 62 LHRH analogues 62 HER2 amplification 62 DOXIL ® 62 cGy 62 Hepsera adefovir dipivoxil 62 PKC# 62 glucocorticoid induced osteoporosis 62 either acutely decompensated 62 medullary thyroid cancer 62 intracranial tumors 62 XELOX 62 Elotuzumab 62 metastatic HRPC 62 PegIFN RBV 62 Gleevec resistant 62 Cytoxan 62 ovarian breast 62 AA amyloidosis 62 GnRH agonist 62 vapreotide acetate 62 AstraZeneca Arimidex 62 Transdrug R 62 ORENCIA ® 62 Chronic Hepatitis C 62 trans retinoic acid ATRA 62 neoplasia PIN 62 Patients Treated 62 FOLFOX chemotherapy 62 Pooled Analysis 62 toenail onychomycosis 62 Azacitidine 62 proctitis 62 Radical prostatectomy 62 osteosarcomas 62 gemtuzumab ozogamicin 62 squamous cell cancers 62 Parathyroid Hormone 62 advanced HER2 positive 62 precancerous condition 62 untreated metastatic pancreatic 62 pancreatic neuroendocrine tumors